Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check6 days agoChange DetectedThe history shows the page updating its revision from v3.5.3 to v3.5.4, indicating a new version of the page has been published.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry v3.5.3 was added to the study record history, and the previous revision v3.5.2 was removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.5.2 was added to the history. The v3.5.0 revision was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the history. The operating-status notice and the previous revision entry, v3.4.1, were removed from the page.SummaryDifference0.5%

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.